Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Axcel VI and the Currentum in connection with the acquisition of Elektro-Emanuel
Mandate

Vinge advises Axcel VI and the Currentum in connection with the acquisition of Elektro-Emanuel

June 19, 2024 M&A Banking and Finance Real Estate and Construction Employment and Benefits

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elektro-Emanuel AB. The company carries out electrical installations for both companies and private individuals and has offices in four cities in western Sweden.

The acquisition is subject to customary regulatory approvals.

Vinge’s team consisted of responsible partner Christina Kokko together with Carl Fredrik Wachtmeister and Alexander Rüdén (M&A), Calle Tengwall Pagels and Frithiof Hallgren Wallin (Banking and finance), Niclas Lindblom (Construction), Hanna Kövamees (Real property), Narin Melazade and Jonatan Stentorp (Labor Law), Daniel Wendelsson, David Olander and Hilda Ivarsson (Regulatory) and Johanna Engström (Transaction Support Coordinator).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

 Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

 Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025